<img alt="" height="1" width="1" />Salix Pharmaceuticals Gets Intellecutual Property Relating to RifaximinTrading Markets (press release)The '240 patent provides protection relating to treating bloating caused by small intestinal bacterial overgrowth associated with irritable bowel syndrome ...<nobr></nobr> |